ClinicalTrials.govpublic full text
A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001
disease, hodgkin, lymphoma, large-cell, anaplastic, lymphoma, non-hodgkin, lymphoma, t-cell, cutaneous
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 343832
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.